ORIC Pharmaceuticals, Inc. (ORIC) Balance Sheet
As of 2026-06-30 (10-Q), ORIC Pharmaceuticals, Inc. (ORIC) reported total assets of $404.7M, total liabilities of $23.4M and shareholders' equity of $381.3M, according to EquiReason's reading of its SEC filings. Cash and equivalents: $37.5M.
Source: SEC EDGAR filings · figures as of 2026-06-30 · read by EquiReason
ORICORIC Pharmaceuticals, Inc.Follow ORIC — free
—
Price chart with a free account
- Market cap
- 1.4B
- P/E TTM
- —
- Dividend yield
- —
- 52-week
- —
- Next earnings
- 9 Nov, in 16 days
| Line | FY2020 Dec 20 | FY2021 Dec 21 | FY2022 Dec 22 | FY2023 Dec 23 | FY2024 Dec 24 | FY2025 Dec 25 | Latest Jun 26 | Trend |
|---|---|---|---|---|---|---|---|---|
| Cash and equivalents | 78.4 | 226.0 | 66.8 | 23.4 | 59.4 | 45.7 | 37.5 | |
| Short-term investments | 215.2 | 11.0 | 139.4 | 184.8 | 196.6 | 235.8 | 227.3 | |
| Current assets | 296.7 | 240.5 | 210.5 | 212.6 | 262.3 | 288.5 | 273.7 | |
| Total assets | 299.0 | 298.6 | 247.2 | 252.0 | 274.1 | 408.9 | 404.7 | |
| Current liabilities | 9.0 | 15.2 | 15.4 | 20.5 | 24.8 | 20.4 | 20.8 | |
| Long-term debt | — | 10.5 | — | — | — | — | — | |
| Total liabilities | 9.2 | 25.7 | 24.8 | 27.9 | 31.0 | 24.5 | 23.4 | |
| Shareholders' equity | 289.8 | 273.0 | 222.4 | 224.1 | 243.1 | 384.4 | 381.3 |
USD millions · SEC XBRL
ORIC Pharmaceuticals, Inc. — questions
- How much cash does ORIC Pharmaceuticals, Inc. have?
- $37.5M in cash and cash equivalents as of 2026-06-30.
- What are ORIC Pharmaceuticals, Inc.'s total assets?
- $404.7M as of 2026-06-30.
- What is ORIC Pharmaceuticals, Inc.'s shareholders' equity?
- $381.3M as of 2026-06-30.
Every figure on this page comes from ORIC Pharmaceuticals, Inc.'s own SEC filings — see them on SEC EDGAR. Price data is licensed and shown only inside the product.
How these figures are read: methodology · EquiReason.